Physician profile
Cristina Marco
NPI 1346900081
$18,034.46
in general payments reported to CMS, 2019-2025
39 companies · $6,460 in 2025
The $6,460 reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $2,230 · 2023: $4,581 · 2024: $4,763 · 2025: $6,460.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $16K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15,804.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $3,471.00 | 2022-2025 | Dexcom G6 Transmitter |
| Novo Nordisk INC | $2,174.67 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Corcept Therapeutics | $1,511.99 | 2022-2025 | Korlym |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,421.61 | 2022-2025 | Jardiance, Synjardy |
| Lilly USA, LLC | $1,278.69 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Abbott Laboratories | $1,125.57 | 2022-2024 | Freestyle Libre 3 |
| Xeris Pharmaceuticals, INC. | $1,006.47 | 2023-2025 | Recorlev, Gvoke Hypopen, Keveyis |
| Sanofi-Aventis U.S. LLC | $669.42 | 2022-2025 | |
| Amgen INC. | $662.90 | 2023-2025 | Repatha, Evenity, Prolia |
| Tandem Diabetes Care, INC. | $648.64 | 2022-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Bayer Healthcare Pharmaceuticals INC. | $644.76 | 2022-2025 | |
| Radius Health, INC. | $596.72 | 2023-2025 | |
| Mannkind Corporation | $488.92 | 2023-2025 | Afrezza, V-Go |
| Ascendis Pharma Endocrinology INC | $405.47 | 2024-2025 | Yorvipath |
| Alexion Pharmaceuticals, INC. | $280.44 | 2023-2025 | Strensiq |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $235.65 | 2025 | Minimed 780g |
| Insulet Corporation | $193.69 | 2025 | Omnipod, Omnipod |
| Sequel Med Tech, LLC | $143.61 | 2025 | Twiist |
| Kyowa Kirin, INC. | $128.52 | 2023 | Crysvita |
| Glaxosmithkline, LLC. | $128.19 | 2025 | Benlysta, Arexvy, Shingrix |
| Ars Pharmaceuticals Operations, INC. | $124.91 | 2025 | Neffy |
| Beta Bionics, INC. | $93.88 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Novartis Pharmaceuticals Corporation | $90.88 | 2025 | |
| Cequr Corporation | $69.24 | 2023-2025 | Cequr Simplicity |
| Antares Pharma, INC. | $55.16 | 2023-2024 | Xyosted, Tlando, Nocdurna |
| Tolmar, INC. | $51.13 | 2023-2025 | Jatenzo |
| Ascensia Diabetes Care US INC. | $47.62 | 2023 | |
| Amphastar Pharmaceuticals, INC. | $39.46 | 2024-2025 | |
| Ionis Pharmaceuticals, INC. | $36.45 | 2025 | Tryngolza |
| Alnylam Pharmaceuticals INC. | $29.94 | 2023 | Onpattro |
| Madrigal Pharmaceuticals | $26.46 | 2024 | Resmetirom |
| Merck Sharp & Dohme LLC | $24.84 | 2023 | Verquvo |
| Astrazeneca Pharmaceuticals Lp | $24.29 | 2023 | Farxiga |
| Embecta Corp. | $24.04 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Amarin Pharma, INC. | $18.72 | 2023 | |
| Pfizer INC. | $18.67 | 2024 | |
| Chiesi USA, INC. | $14.83 | 2025 | Mycapssa |
| Smith+Nephew, INC. | $13.88 | 2023 | Collagenase Santyl |
| Halozyme INC | $13.13 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cristina Marco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.